Diabetes is a group of metabolic diseases in which a person has high blood sugar which is either due to the fact that insulin produced by the body is not enough or the body does not respond to the insulin that is produced in the body. Mainly there are three type of diabetes: Type 1 diabetes, Type 2 diabetes and gestational diabetes. Pre-diabetes is a condition that occurs when blood glucose level of a person is higher than normal but not high enough so as to diagnose for type 2 diabetes. Depending upon the speed at which the injected insulin is absorbed by the body, different types of insulin devices are available in the market. Diabetic population has been continuously increasing over the years. There are several factors responsible for increase in diabetic population like family history, obesity, smoking, alcohol, hypertension, etc.

Just the way human insulin replaced animal insulin, modern insulin is on the path of replacing human insulin. Ageing population and obesity are among the key drivers of diabetes market. Due to rising aging population, the probability of prevalence of chronic disease also increases which is a major cause of more and more people having diabetes. Urbanization leading to modern lifestyle also deeply influences the health of the people, thereby increasing the diabetic population.

Europe has the largest diabetic population and the largest insulin market followed by North America. Diabetes prevalence rate is high in the US and China. Novo Nordisk, Takeda, Sanofi-Aventis, Eli Lilly, Merck and GSK are among the largest players in diabetes market.

The report analyzes the global diabetes market including the US, Europe, Africa, South and Central America, South and Asia-Pacific. Key issues like lack of sufficient diagnosis and treatment facilities, cost and effective management have also been included in this report. The competition prevailing in the diabetes market has been analyzed with focus on global and regional market share of major players in diabetes and insulin market. The report also profiles the major players in the diabetes market.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the global diabetic population. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

1. Introduction to Diabetes

Types of Diabetes
Treatment Options

2. Global Diabetes Market

Growth of Diabetic Population
Market by Treatment Products
Major Branded Drugs
Prevalence Rates
Insulin Market Segments

3. Diabetes Market - Regional Analysis

3.1 The US Diabetes Market

Growth of Diabetic Population
Market Analysis
Continuous Glucose Market
Insulin Market
Insulin Pump Market
Major Players

3.2 European Diabetes Market

Diabetes Market
Regional Breakdown
Insulin Pump Market

3.3 African Diabetes Market

Market Overview
Market Size

3.4 Middle East/North Africa Diabetes Market

Market Overview
Market Size

3.5 North America/Caribbean Diabetes Market

Market Overview
Market Size

3.6 South & Central America Diabetes Market

Market Overview
Market Size

3.7 South-East Asia Diabetes Market
Market Overview
Market Size

3.8 Western Pacific Diabetes Market

Market Overview
Market Size

4. Market Dynamics

4.1 Key Trends

4.1.1 Replacement of Human Insulin by Modern Insulin
4.1.2 Development of New Insulin Devices
4.1.3 Sedentary Lifestyle
4.1.4 Family History & Genetics

4.2 Growth Drivers

4.2.1 Increasing Aging Population
4.2.2 Increasing Urbanization

4.3 Major Issues

4.3.1 Lack of Sufficient Diagnosis & Treatment
4.3.2 Diabetes Cost- A Burden for Family & Society
4.3.3 Effective Management of Diabetes

5. Diabetes Market - Competitive Landscape

5.1 Global

Diabetes Market Share
Insulin Market Share
Insulin Analogues Market
Insulin Pump Market Share
Continuous Glucose Monitor Market Share

5.2 The EU
5.3 China
5.4 Japan

6. Company Profiles

6.1 Novo Nordisk

Business Description
Key Financials
Business Strategies
Improving Global Presence
Undertaking Innovation
Focus on Human Resources

6.2 Takeda

Business Description
Key Financials
Business Strategies
Accelerating Growth Strategy
Recruiting & Developing Global Talent
Global Quality Assurance Policy

6.3 Sanofi-aventis

Business Description
Key Financials
Business Strategies
Increasing R&D Initiatives
External Growth Opportunities
Adapting to Future Challenges

6.4 Eli Lilly

Business Description
Key Financials
Business Strategies
Providing Quality Assurance
Focus on Research & Development

7. Market Outlook

7.1 Market Forecast
7.2 Forecast Methodology
7.2.1 Dependent and Independent Variables
7.2.2 Correlation Analysis
7.2.3 Regression Analysis

List of Charts

Global Diabetic Population (2004-2010)
Global Diabetes Population- by Geographical Segments (2010 & 2030E)
Global Diabetes Market- by Treatment Product (2009)
Global Diabetes Prevalence Rates (2010)
Global Insulin Market – by Segments (2010)
Global Insulin Market – by Geographical Segments (2010)
No. of New Cases of Diagnosed Diabetes in US (2010E)
US Continuous Glucose Market (2010)
US Insulin Market Share (2010)
US Insulin Pump Market Share (2010 & 2015E)
Diabetes Patients in Western Europe (2010)
Insulin Analog- by Types- by Volume (2009)
Types of Insulin Devices- by Volume (2009)
Increasing Aging Population over 65 years (2005-2012E)
Increasing Urban Population (2005-2010)
Global Diabetes Market Share- by Company (2010)
Global Total & Modern Insulin Market Share – by Volume (2010)
Global Insulin Market Share – by Value (2010)
Global Insulin Analogues Market Share–by Volume (2009)
Global Continuous Glucose Monitor Market Share (2010E)
Global Blood Glucose Testing Market Share (2010)
Global Insulin Pump Market Share (2010)
Global Insulin Pump Market Share (2009)
EU Modern Insulin Market Share (2010)
China Insulin Market Share (2010)
Japan Insulin Market Share (2010)
Sales of Novo-Nordisk (2006-2010)
Sales of Novo-Nordisk- by Business Segments (2010)
Net Sales of Takeda (2007-2011)
Net Sales of Takeda- by Business Segments (2011)
Net Sales of Sanofi-Aventis (2006-2010)
Net Sales of Sanofi-Aventis- by Business Segments (2010)
Revenue of Ely Lilly (2006-2010)
Revenue of Ely Lilly- by Products (2010)
Revenue of Ely Lilly- by Geographical Segments (2010)
Global Diabetic Population (2007-2014E)

List of Tables

Key Branded Diabetes Drugs (2009)
Global Leading Market Share Position- by Volume (2009)
Diagnosed & Undiagnosed Diabetes among People in the US (2010)
Continuous Glucose Market- Home Use Market Opportunity (2010)
US Diabetes Market Model (2008-2016E)
US Market for ICU Continuous Glucose Monitoring (2009)
Continuous Glucose Monitoring Comparison (2010)
Major Players in the US Diabetes Market
Key Insulin Pump Devices in Development in the US
EU Insulin Pump Market (2008-2015E)
Diabetes Market in Europe (2010E/2030E)
Diabetes Market in Africa (2010E/2030E)
Diabetes Market in Middle East and North Africa (2010E/2030E)
Diabetes Market in North America and Caribbean (2010E/2030E)
Diabetes Market in South and Central America (2010E/2030E)
Diabetes Market in South East Asia (2010E/2030E)
Diabetes Market in Western Pacific (2010E/2030E)
Dependent & Independent Variables (2005– 2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output